PRESS RELEASE published on 07/23/2024 at 07:30, 1 year 9 months ago Inside Information / News release on accounts, results GenSight Biologics reports cash position of €6.9 million as of June 30, 2024, with potential over 100 vials available upon Q3 resumption of early access program. Company confirms sufficient working capital and successful blending step for LUMEVOQ drug product Working Capital Business Update Cash Position GenSight Biologics LUMEVOQ Drug Product
PRESS RELEASE published on 07/23/2024 at 07:30, 1 year 9 months ago Informations privilégiées / Communiqué sur comptes, résultats GenSight Biologics publie sa position de trésorerie au 30 juin 2024, et fait le point sur ses activités. La trésorerie s'élève à 6,9 millions d'euros, suffisante jusqu'au quatrième trimestre 2024 Trésorerie GenSight Biologics Thérapies Géniques Activités LUMEVOQ
REGULATED PRESS RELEASE published on 07/23/2024 at 07:02, 1 year 9 months ago Thales publie ses résultats semestriels 2024
REGULATED PRESS RELEASE published on 07/23/2024 at 07:02, 1 year 9 months ago Thales reports its 2024 half-year results
PRESS RELEASE published on 07/23/2024 at 07:00, 1 year 9 months ago Julius Baer appoints Stefan Bollinger as Chief Executive Officer Julius Baer appoints Stefan Bollinger, Partner at Goldman Sachs, as new CEO starting in early 2025, following a comprehensive search. Bollinger brings 3 decades of experience in financial markets and global banking CEO Appointment Goldman Sachs Julius Baer Stefan Bollinger Private Wealth Management
PRESS RELEASE published on 07/23/2024 at 07:00, 1 year 9 months ago Lindt & Sprüngli achieves robust growth in sales and profits – outlook for 2024 confirmed Lindt & Sprüngli reports strong growth in sales and profits for the first half of 2024, with an EBIT margin increase. Outlook for 2024 confirmed with new share buyback program Share Buyback Sales Growth Outlook Lindt & Sprüngli Profits
PRESS RELEASE published on 07/23/2024 at 07:00, 1 year 9 months ago Quarterly statement six months 2024 Amadeus Fire Group reports 4.3% revenue growth in H1 2024 despite economic challenges. Operating EBITA down 12.1%, Training segment shows positive development Revenue Growth Operating EBITA H1 2024 Training Segment Amadeus Fire
PRESS RELEASE published on 07/23/2024 at 07:00, 1 year 9 months ago FORVIA HELLA publishes half-year results 2024: Slight improvement in sales and earnings in a challenging market environment FORVIA HELLA reports slight sales and earnings improvement in H1 2024 despite challenging market conditions. Detailed financial results and outlook provided Market Environment Half-year Results FORVIA HELLA Earnings Improvement Sales Improvement
REGULATED PRESS RELEASE published on 07/23/2024 at 07:00, 1 year 9 months ago Edenred : résultats semestriels 2024
REGULATED PRESS RELEASE published on 07/23/2024 at 07:00, 1 year 9 months ago Edenred : First-half 2024 results
Published on 05/08/2026 at 01:50, 2 hours 24 minutes ago Apex Critical Metals Announces Grant of Stock Options and RSUs
Published on 05/08/2026 at 00:45, 3 hours 29 minutes ago Route1 Announces First Quarter 2026 Financial Results Notification
Published on 05/08/2026 at 00:00, 4 hours 14 minutes ago Redwood AI Approved to Receive National Research Council of Canada Funding for its Q-SAFE Chemical Screening Project for Defence and Security Applications
Published on 05/07/2026 at 23:30, 4 hours 44 minutes ago Faraday Copper Reports First Quarter 2026 Financial Results
Published on 05/07/2026 at 23:15, 4 hours 59 minutes ago BULGOLD Adopts Semi-Annual Financial Reporting
Published on 05/07/2026 at 23:23, 4 hours 51 minutes ago H1 25/26: Challenging environment and significant changes in IT market // Revised forecast // Programme to boost competitiveness
Published on 05/07/2026 at 23:14, 5 hours ago EQS-Adhoc: All for One Group SE revises forecast for 2025/26 financial year // »Precision« programme to boost competitiveness approved
Published on 05/07/2026 at 22:05, 6 hours 9 minutes ago Univar Solutions Announces Leadership Evolution
Published on 05/07/2026 at 20:42, 7 hours 32 minutes ago RHÖN-KLINIKUM AG reports stable development in the first quarter of 2026
Published on 05/07/2026 at 18:46, 9 hours 28 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/07/2026 at 19:15, 8 hours 59 minutes ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 8 hours 59 minutes ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 9 hours 8 minutes ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 9 hours 8 minutes ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 9 hours 14 minutes ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL